Market Share of Liver Diseases Therapeutics Industry
The liver disease therapeutics market is fragmented, with many prominent players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies that are currently dominating the market are Abbott Laboratories, Gilead Sciences, Novartis AG, Sanofi, and Astellas Pharma, Inc., among others.
Liver Disease Therapeutics Market Leaders
Abbott Laboratories
Gilead Sciences
Novartis AG
Sanofi
Astellas Pharma Inc.
*Disclaimer: Major Players sorted in no particular order
